Contrasting patterns of hepatitis C virus infection in two regions from Tunisia

Journal of Medical Virology

Volumn 76, Issue 2, 2005, Pages 185-193

  Mejri, S ^a   Ben Salah, A ^a   Triki, H ^a   Ben Alaya, N ^a   Djebbi, A ^a   Dellagi, K ^a  

^a PASTEUR INSTITUTE OF TUNIS   (Tunisia)

Author keywords

Genotypes; Hepatitis C virus; Phylogenetic analyses; Prevalence; Tunisia

Indexed keywords

VIRUS DNA;

5' UNTRANSLATED REGION; ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CONTROLLED STUDY; DISEASE COURSE; ENZYME IMMUNOASSAY; FAMILY; FEMALE; GENDER; GENETIC HETEROGENEITY; GENOTYPE; GEOGRAPHIC DISTRIBUTION; GROUPS BY AGE; HEPATITIS C; HEPATITIS C VIRUS; HOUSEHOLD; HUMAN; IMMUNOBLOTTING; INFANT; INTRAFAMILIAL TRANSMISSION; MAJOR CLINICAL STUDY; MALE; MOLECULAR PHYLOGENY; NEWBORN; NORTH AFRICA; NUCLEOTIDE SEQUENCE; PHYLOGENY; POLYMERASE CHAIN REACTION; POPULATION RESEARCH; PREVALENCE; RISK FACTOR; RURAL POPULATION; SEQUENCE ANALYSIS; STATISTICAL SIGNIFICANCE; TUNISIA; URBAN POPULATION; VIRUS DETECTION; VIRUS GENOME; VIRUS STRAIN; VIRUS TRANSMISSION; VIRUS TYPING;

5' UNTRANSLATED REGIONS; ADOLESCENT; ADULT; AGE FACTORS; AGED; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; DNA, VIRAL; FAMILY; FEMALE; GENOTYPE; HEPACIVIRUS; HEPATITIS C; HEPATITIS C ANTIBODIES; HUMANS; IMMUNOBLOTTING; IMMUNOENZYME TECHNIQUES; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; PHYLOGENY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RISK FACTORS; RNA, VIRAL; SEQUENCE ANALYSIS, DNA; TUNISIA;

EID: 17844382112     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/jmv.20342     Document Type: Article

References (61)

1. Abdel-Aziz F, Habib M, Mohamed MK, Abdel-Hamid M, Gamil F, Madkour S, Mikhail NN, Thomas D, Fix AD, Strickland GT, Anwar W, Sallam I. 2000. Hepatitis C virus (HCV) infection in a community in the Nile Delta: Population description and HCV prevalence. Hepatol 32:111-115.
2. Abid S, Fkih S, Khlass B, Cherif W, Toumi NH, Jenhani F, Boukef K. 1997. Screening and confirmation of anti-HCV antibodies in Tunisian blood donors. Transfus Clin Biol 4:221-226.
3. Ackerman Z, Ackerman E, Paltiel O. 2000. Intrafamilial transmission of hepatitis C virus: A systematic review. J Viral Hep 7:93-103.
4. Akhtar S, Moatter T, Azman SI, Rahbar MH, Adil S. 2002. Prevalence and risk factors for intrafamilial transmission of hepatitis C virus in Karachi, Pakistan. J Viral Hep 9:309-314.
5. Alter MJ, Margolis HS, Krawczynski K, Judson FN, Mares A, Alexander WJ, Hu PY, Miller JK, Gerber MA, Sampliner RE, Emory MD, Meeks L, Beach MJ. 1992. The natural history of community-acquired hepatitis c in the United States. N Engl J Med 327:1899-1905.
6. Ayed Z, Houinato D, Hocine M, Ranger-Rogez S, Denis F. 1995. Prevalence of serum markers of hepatitis B and C in blood donors and pregnant women in Algeria. Bul Soc Path Ex 88:225-228.
7. Benani A, El-Turk J, Benjelloun S, Sekkat S, Nadifi S, Hda N, Benslimane A. 1997. HCV genotypes in Morocco. J Med Vir 52:396-398.
8. Benjelloun S, Bahbouhi B, Sekkat S, Bennani A, Hda N, Benslimane A. 1996. Anti-HCV seroprevalence and risk factors of hepatitis C virus infection in Moroccan population groups. Res Virol 147:247-255.
9. Centers for Disease Control. 1994. Hepatitis Surveillance Report, Vol. 55. pp 1-35.
10. Chan SW, McOmish F, Holmes EC, Dow B, Peutherer JF, Follett E, Yap PL, Simmonds P. 1992. Analysis of a new hepatitis C virus type and its phylogenetic relationship to existing variants. J Gen Vir 73:1131-1141.
11. Chomczynski P, Sacchi N. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159.
12. Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M. 1989. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 244:359-362.
13. Desenclos JC, Bourdiol-Razes M, Rolin B, Garandeau P, Ducos J, Brechet C, Thiers V. 2001. Hepatitis C in a ward for cystic fibrosis and diabetic patients: Possible transmission by spring-loaded finger-stick devices for self-monitoring of capillary blood glucose. Infect Control Hosp Epidemiol 22:701-707.
14. Djebbi A, Triki H, Bahri O, Cheikh I, Sadraoui A, Ben Ammar A, Dellagi K. 2003. Genotypes of hepatitis C virus circulating in Tunisia. Epidemiol Infect 130:501-505.
15. Felsenstein J. 1993. PHYLIP (Phylogeny Inference Package) version 3.5c. Department of Genetics, University of Washington: http://www.caos.kun.nl/cammsa/ PHYLIP/.
16. Frank C, Mohamed MK, Strickland GT, Lavanchy D, Arthur RR, Magder LS, El Khoby T, Abdel-Wahab Y, Aly Ohn ES, Anwar W, Sallam I. 2000. The role of antishistosomal therapy in the spread of hepatitis C virus in Egypt. Lancet 355:887-891.
17. Gorgi Y, Yalaoui S, Ben Nejma HL, Azzouz MM, Hsairi M, Ben Khelifa H, Ayed K. 1998. Dépistage de l'hépatite virale C dans la population générale en Tunisie. Bull Soc Path Ex 91:177.
18. Hara T, Setoguchi Y, Kajihara S, Yamamoto K, Sakai T, Inoue T, Ohba K, Mizokami M. 1996. Phylogenetic tree-based epidemiological analysis of hepatitis c virus transmission in a region of Japan with a high prevalence of infection. J Gastroenterol Hepatol 11:641-645.
19. Herrine SK. 2002. Approach to the patient with chronic Hepatitis C Virus infection. Ann intern Med 136:747-757.
20. Hibbs RG, Corwin AL, Hassan NF, Kamel M, Darwish M, Edelman R, Constantine NT, Rao MR, Khalifa AS, Mokhtar S, Fam NS, Ekladious EM, Bassily SB. 1993. The epidemiology of antibody to hepatitis C in Egypt. J Infect Dis 168:789-790.
21. Higgins DG, Sharp PM. 1988. CLUSTAL: A package for performing multiple sequence alignment on a microcomputer. Gene 73:237-244.
22. Hyams KC, Okoth FA, Tukei PM, Vallari DS, Morrill JC, Long G, Bansal J, Constantine N. 1993. Inconclusive hepatitis C virus antibody results in African sera. J Infect Dis 167:254-255.
23. Ilako FM, McLigeyo SO, Ryat MS, Lule GN, Okoth FA, Kaptich D. 1995. The prevalence of hepatitis C virus antibodies in renal patients, blood donors and patients with chronic liver disease in Kenya. East Afr Med J 72:362-364.
24. Ito S-I, Ito M, Cho M-J, Shimotohno K, Tajima K. 1991. Massive sero-epidemiological survey of hepatitis C virus: Clustering of carriers on the southwest coast of Tsushima, Japan. Jpn J Cancer Res 82:1-3.
25. Keiserman DR, Both CT, Mattos AA, Remiao J, Alexandre CO, Sherman KE. 2003. Intrafamilial transmission of hepatitis C virus in patients with hepatitis C and human immunodeficiency virus coinfection. Am J Gastroenterol 98:878-883.
26. Kirn YS, Chi HS, Ahn YO, Lee HS, Klag MJ. 1998. Lack of familial clustering of hepatitis C virus infection. Int J Epidemiol 27:525-529.
27. Kumar S, Tamura K, Nei M. 1994. MEGA: Molecular Evolutionary Genetics Analyses software for microcomputers. Comput Appl Biosci 10:189-191.
28. Lionis C, Vlachonikolis IG, Skliros S, Symeonidis A, Merkouris BP, Kouroumalis E, and the Hepatitis C Working Group of the Greek General Practitioners. 2000. Do undefined sources of hepatitis C transmission exist? The Greek study in general practice. J Viral Hepat 7:218-224.
29. MacDonald M, Krofts N, Kaldor J. 1996. Transmission of hepatitis C virus: Rates, routes and cofactors. Epidemiol Rev 18:137-148.
30. Maertens G, Stuyver L. 1997. Genotypes and genetic variation of hepatitis C virus. In: Harrison TJ, Zuckerman AJ, editors. The molecular medicine of viral hepatitis. John Wiley & Sons Ltd. pp 183-233.
31. Rao MR, Naficy AB, Darwish MA, Darwish NM, Schisterman E, Clemens JD, Edelman R. 2002. Further evidence for association of hepatitis C infection with parenteral schistosomiasis treatment in Egypt. BMC Infectious Diseases 2:29.
32. Mast EE. 2004. Mother-to-infant hepatitis C virus transmission and breastfeeding. Adv Exp Med Biol 554:211-216.
33. Memon MI, Memon MA. 2002. Hepatitis C: An epidemiological review. J Viral Hepat 9:84-100.
34. Miller RH, Purcell RH. 1990. Hepatitis C virus shares amino acid similarity with pestiviruses and flaviviruses as well as members of two plant virus supergroups. Proc Natl Acad Sci USA 87:2057-2061.
35. Ndumbe PM, Skalsky J. 1993. Hepatitis C virus infection in different populations in Cameroon. Scand J Infect Dis 25:689-692.
36. Noguchi S, Sata M, Suzuki H, Mizokami M, Tanikawa K. 1997. Routes of transmission of hepatitis C virus in an endemic rural area of Japan. Molecular epidemiologic study of hepatitis c virus infection. Scand J Infect Dis 29:23-28.
37. Page RDM. 1996. TREEVIEW: An application to display phylogenetic trees on personal computers. Comput Appl Biosci 12:357-358.
38. Rail CJN, Dienstag JL. 1995. Epidemiology of hepatitis C virus infection. Semin Gastrointest Dis 6:3-12.
39. Robertson B, Myers G, Howard C, Brettin T, Bukh J, Gaschen B, Gojobori T, Maertens G, Mizokami M, Nainan O, Netesov S, Nishioka K, Shin IT, Simmonds P, Smith D, Stuyver L, Weiner A. 1998. Classification, nomenclature and database development for hepatitis C virus (HCV) and related viruses: Proposals for standardization. International Committee on Virus Taxonomy. Arch Virol 143:2493-2503.
40. Saltoglu N, Tasova Y, Burgut R, Dundar IH. 1998. Sexual and non-sexual intrafamilial spread of hepatitis C virus: Intrafamilial transmission of HCV. Eur J Epidemiol 14:225-228.
41. Sharara AI, Hunt CM, Hamilton JD. 1996. Hepatitis C. Ann Intern Med 125:658-668.
42. Shin HR, Kim JY, Ohno T, Cao K, Mizokami M, Risch H, Kim SR. 2000. Prevalence and risk factors of hepatitis C virus infection among Koreans in rural area of Korea. Hepatol Res 17:185-196.
43. Shobokshi OA, Serebour FE, Skakni LI. 2003. Hepatitis C genotypes/subtypes among chronic hepatitis patients in Saudi Arabia. Saudi Med J 24:S87-S91.
44. Slama H, Mojaat N, Dahri R, Boukef K. 1991. Etude épidé miologique des anticorps anti-HCV chez les donneurs de sang en Tunisie. Rev Fr Transfus Hémobiol 34:459-464.
45. Slama H, Mojaat N, Bjaoui M, Durant F, Gueguen D, Boukef K, Genetet B. 1992. Prevalence of hepatitis C in multitransfused Tunisian patients. Nouv Rev Hematol 34:301-302.
46. Smith DB, Mellor J, Jarvis LM, Davidson F, Kolberg J, Urdea M, Yap PL, Simmonds P. 1995. Variation of the hepatitis C virus 5′ non-coding region: Implication for secondary structure, virus detection and typing. The International HCV Collaborative Study Group. J Gen Vir 76:1749-1761.
47. Ray SC, Ray AR, Carella A, Bukh J, Thomas DL. 2000. Genetic Epidemiology of Hepatitis C Virus throughout Egypt. J Infect Dis 182:698-707.
48. Sun CA, Chen HC, Lu CF, You SL, Mau YC, Ho MS, Lin SH, Chen CJ. 1999. Transmission of hepatitis c virus in Taiwan: Prevalence and risk factor based on a nationwide survey. J Med Virol 59:290-296.
49. Takada N, Takase S, Takada A, Date T. 1993. Differences in the hepatitis C virus genotypes in different countries. J Hepatol 17:277-283.
50. Tess BH, Levin A, Brubaker G, Shao J, Drummond JE, Alter HJ, O'Brien TR. 2000. Seroprevalence of hepatitis C virus in the general population of northwest Tanzania. Ame J Trop Med Hyg 62:138-141.
51. Thiers V, Jaffredo F, Tuveri R, Chodan N, Brechot C. 1997. Development of a simple restriction fragment length polymorphism (RFLP) based assay for HCV genotyping and comparative analysis with genotyping and serotyping tests. J Vir Methods 65:9-17.
52. Tibbs CJ, Palmer SJ, Coker R, Clark SK, Parsons GM, Hojvat S, Peterson D, Banatvala JE. 1991. Prevalence of hepatitis C in tropical communities: The importance of confirmatory assays. J Med Virol 34:143-147.
53. Touzet S, Kraemer L, Colin C, Pradat P, Lanoir D, Bailly F, Coppola RC, Sauleda S, Thursz MR, Tillmann H, Alberti A, Braconier JH, Esteban JI, Hadziyannis SJ, Manns MP, Saracco G, Thomas HC, Trepo C. 2000. Epidemiology of hepatitis C virus infection in seven European Union countries: A critical analysis of the literature. HENCORE Group. (Hepatitis C European Network for Co-operative Research. Eur J Gastroenterol Hepatol 12:667-678.
54. Triki H, Said N, Ben Salah A, Arrouji A, Ben Ahmed F, Bouguerra A, Hmida S, Dhahri R, Dellagi K. 1997. Seroepidemiology of hepatitis B, C and delta viruses in Tunisia. Trans R Soc Trop Med Hyg 91:11-14.
55. Twaraya H, Ohkoshi S, Kuwana K, Watanabe M, Kamimura T, Asakura H. 1995. Epidemiologic survey and genetic analysis of endemic hepatitis c virus infection in a Japanese town with a high prevalence of hepatitis B virus carriers. J Med Virol 45:367-372.
56. Van Damme P, Thyssen A, Van loock F. 2002. Epidmiology of hepatitis C in Belgium: Present and future. Acta Gastroenterol Bel 65:78-79.
57. Van der Poel CL, Cuypers HT, Reesnik HW. 1994. Hepatitis C virus six years on. Lancet 344:1475-1479.
58. World Health Organization. 1997. Hepatitis C: Global prevalence. Wkly Epidemiol Rec 72:341-344.
59. World Health Organization. 2002. Wkly Epidemiol Rec Number 6.
60. Yoshii E, Shinzawa H, Saito T, Shao L, Kuboki M, Saito K, Togashi H, Takahashi T, Mizokami M. 1999. Molecular epidemiology of hepatitis C virus infection in an area endemic for community-acquired acute hepatitis C. Tohoku J Exp Med 188:311-316.
61. Zein NN. 2000. Clinical significance of hepatitis C virus genotypes. Clin Microbiol Rev 13:223-235.